377 related articles for article (PubMed ID: 20082483)
1. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
[TBL] [Abstract][Full Text] [Related]
2. Associations between NOD2, IRGM and ORMDL3 polymorphisms and pediatric-onset inflammatory bowel disease in the Lithuanian population.
Pranculienė G; Steponaitienė R; Skiecevičienė J; Kučinskienė R; Kiudelis G; Adamonis K; Labanauskas L; Kupčinskas L
Medicina (Kaunas); 2016; 52(6):325-330. PubMed ID: 27932194
[TBL] [Abstract][Full Text] [Related]
3. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Cucchiara S; Riegler G; Staiano AM; Ardizzone S; Accomando S; de Angelis GL; Corritore G; Bossa F; Annese V
World J Gastroenterol; 2008 Aug; 14(29):4643-51. PubMed ID: 18698678
[TBL] [Abstract][Full Text] [Related]
4. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA
Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
[TBL] [Abstract][Full Text] [Related]
5. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E
World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
Csöngei V; Járomi L; Sáfrány E; Sipeky C; Magyari L; Faragó B; Bene J; Polgár N; Lakner L; Sarlós P; Varga M; Melegh B
World J Gastroenterol; 2010 Jan; 16(2):176-83. PubMed ID: 20066736
[TBL] [Abstract][Full Text] [Related]
7. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients.
Lakatos PL; Szamosi T; Szilvasi A; Molnar E; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Tulassay Z; Miheller P; Papp J; Tordai A; Andrikovics H;
Dig Liver Dis; 2008 Nov; 40(11):867-73. PubMed ID: 18499543
[TBL] [Abstract][Full Text] [Related]
8. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
[TBL] [Abstract][Full Text] [Related]
9. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms present in IL10, IL23R, NOD2, and ATG16L1 associated with susceptibility to inflammatory bowel disease in Mexican population.
Quiroz-Cruz S; Posada-Reyes B; Alatorre-García T; Del Real-Calzada CM; García-Samper X; Escobar-Gutiérrez A; Vázquez-Chacón CA; Martínez-Guarneros JA; Cruz-Rivera M; Vaughan G; Fonseca-Coronado S
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):10-16. PubMed ID: 31651650
[TBL] [Abstract][Full Text] [Related]
11. Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?
Hoffmann P; Lamerz D; Hill P; Kirchner M; Gauss A
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198814
[TBL] [Abstract][Full Text] [Related]
12. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
[TBL] [Abstract][Full Text] [Related]
13. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
14. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
[TBL] [Abstract][Full Text] [Related]
15. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
[TBL] [Abstract][Full Text] [Related]
16. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.
Rigoli L; Romano C; Caruso RA; Lo Presti MA; Di Bella C; Procopio V; Lo Giudice G; Amorini M; Costantino G; Sergi MD; Cuppari C; Calabro GE; Gallizzi R; Salpietro CD; Fries W
World J Gastroenterol; 2008 Jul; 14(28):4454-61. PubMed ID: 18680223
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
Weersma RK; Stokkers PC; Cleynen I; Wolfkamp SC; Henckaerts L; Schreiber S; Dijkstra G; Franke A; Nolte IM; Rutgeerts P; Wijmenga C; Vermeire S
Am J Gastroenterol; 2009 Mar; 104(3):630-8. PubMed ID: 19174780
[TBL] [Abstract][Full Text] [Related]
19. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
[TBL] [Abstract][Full Text] [Related]
20. Association of IL23R and ATG16L1 with susceptibility of Crohn's disease in Chinese population.
Zhang J; Chen J; Gu J; Guo H; Chen W
Scand J Gastroenterol; 2014 Oct; 49(10):1201-6. PubMed ID: 25048429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
